Timothy A. McCaffrey

City:

Silver Spring, Maryland

Country:

United States

Published Applications:

Last publication date:

2022-09-22

Top Assignees for applications by Timothy A. McCaffrey

The entities that hold a legal rights for patent applications filed by inventor McCaffrey Timothy A.:

The George Washington University a Congressionally Chartered Not-for Profit Corporation 4 Washington, DC United States
The George Washington University 2 Washington, DC United States
The St. Laurent Institute 1 Vancouver, WA United States
CapGen Sciences, Inc. 1 Elliocott City, MD United States
ASTUTE MEDICAL, INC. 1 San Diego, CA United States
THE GEORGE WASHINGTON UNIVERSITY A CONGRESSIONAL CHARTERED NOT-FOR-PROFIT CORPORATION 1 Washington, DC United States

Recent patent applications by McCaffrey Timothy A.

Timothy A. McCaffrey from Silver Spring, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-09-22

US20220298574A1

Chemistry; metallurgy

BLOOD BIOMARKERS FOR APPENDICITIS AND DIAGNOSTICS METHODS USING BIOMARKERS

#2 | 2022-08-04

US20220243273A1

Chemistry; metallurgy

Blood RNA biomarkers of coronary artery disease

#3 | 2022-03-24

US20220090199A1

Chemistry; metallurgy

Blood biomarkers for appendicitis and diagnostics methods using biomarkers

#4 | 2021-03-04

US20210062266A1

Chemistry; metallurgy

Blood biomarkers for respiratory infections

#5 | 2018-05-17

US20180135127A1

Chemistry; metallurgy

Blood biomarkers for appendicitis and diagnostics methods using biomarkers

#6 | 2018-03-01

US20180057882A1

Chemistry; metallurgy

BLOOD RNA BIOMARKERS OF CORONARY ARTERY DISEASE

#7 | 2017-12-28

US20170369946A1

Chemistry; metallurgy

Blood biomarkers for respiratory infections

#8 | 2017-12-14

US20170356908A1

Physics

Blood biomarkers for appendicitis and diagnostics methods using biomarkers

#9 | 2009-06-04

US20090142756A1

Chemistry; metallurgy

Prediction of bare metal stent restenosis

#10 | 2008-03-06

US20080057098A1

Human necessities

Use of Bcl inhibitors for the prevention of fibroproliferative reclosure of dilated blood vessels and other iatrogenic fibroproliferative disorders

InventorID:

2063720 ⎘